Amanda Gollo Bertollo | Neuropharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Amanda Gollo Bertollo | Neuropharmacology | Best Researcher Award

Federal University of Santa Catarina | Brazil

Mrs. Amanda Gollo Bertollo is an accomplished biomedical and neuroscience researcher with extensive experience across molecular biology, genetics, and biomedicine. Currently, she serves as a Biology Expert at Turing, providing expert review and guidance on molecular biology and genetics tasks to ensure scientific accuracy in AI-driven projects. She is pursuing her Ph.D. in Neurosciences at the Federal University of Santa Catarina, focusing on the hypothalamus-pituitary-adrenal and gut-brain axes in the biological interaction pathways of depression. Her research portfolio spans neuroscience, psychiatric disorders, and molecular mechanisms underlying mental health conditions.Previously, Mrs. Bertollo completed her Master’s in Biomedical Sciences at the Federal University of Fronteira Sul, where she conducted advanced research, authored, and critically reviewed scientific publications. She has also gained hands-on clinical and teaching experience as a Portuguese Writing Specialist at Outlier, a Personal English Teacher, and an English Instructor at Wizard Idiomas, developing personalized curricula and evaluating the accuracy of academic and creative content. Her practical biomedical training includes supervised internships in neurology at Western Regional Hospital and at the Family Health Center, where she contributed to patient care and clinical research activities. She earned her Bachelor of Science in Nursing from the Federal University of Fronteira Sul, providing a strong foundation in patient care, biomedical research, and clinical practice. Additionally, she is pursuing undergraduate studies in Computer Science, reflecting her interdisciplinary approach bridging computational methods with biological and clinical research.Mrs. Bertollo has authored and contributed to numerous influential publications, including “Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression,” “Neurobiological Relationships Between Neurodevelopmental Disorders and Mood Disorders,” and “Biological rhythms and psychiatric symptoms in COVID-19 individuals: a cross-sectional multicentric study.” Her work further explores topics such as the impact of melatonin on cytokine storms and purinergic receptor modulation for COVID-19 prognosis, dementia and depression connections with amyloid β protein, early life stress and major depressive disorder, depressive-like behaviors influenced by Centella asiatica extracts, neurobiological mechanisms in the kynurenine pathway, peripheral biomarkers predicting COVID-19 prognosis, and the role of ABO blood type and metabolic markers in COVID-19 susceptibility and severity. Through her multidisciplinary research, Mrs. Bertollo has made substantial contributions to the understanding of neurobiological pathways, psychiatric disorders, and the clinical implications of metabolic and immunological biomarkers, establishing herself as a rising expert in neurosciences and biomedical sciences.

Profile: Orcid

Featured Publications

Bertollo, A. G., Santos, C. F., Bagatini, M. D., & Ignácio, Z. M. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Frontiers in Neuroscience.

Bertollo, A. G., Mocelin, R., & Ignácio, Z. M. Pharmacogenetics and the response to antidepressants in major depressive disorder. Pharmaceuticals.

Mattia-Maximiano, B. C., Mioranza-Koppe, M., Silva, R. H., Arent, C. O., Amboni, G., Pedro, L. C., Bertollo, A. G., Dellazeri Cortez, A., de Medeiros, J., Pedrotti Moreira, F., et al. Biological rhythms and psychiatric symptoms in COVID-19 individuals: a cross-sectional multicentric study. Biological Rhythm Research.

Bertollo, A. G., Puntel, C. F., da Silva, B. V., Martins, M., Bagatini, M. D., & Ignácio, Z. M. Neurobiological relationships between neurodevelopmental disorders and mood disorders. Brain Sciences.

Bertollo, A. G., Mingoti, M. E. D., & Ignácio, Z. M. Neurobiological mechanisms in the kynurenine pathway and major depressive disorder. Reviews in the Neurosciences.

Bertollo, A. G., da Silva, B. V., Martins, M., Bagatini, M. D., & Ignácio, Z. M. Neurobiological relationships between neurodevelopmental disorders and mood disorders.

Liangxing Tu | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Liangxing Tu | Drug Delivery Systems | Best Researcher Award

Jiangxi University of Chinese Medicine | China

Prof. Dr. Liangxing Tu is a distinguished pharmaceutical scientist recognized for his extensive contributions to drug delivery systems and biopharmaceutics. He earned his Ph.D. in Pharmaceutics from the Shanghai University of Traditional Chinese Medicine, where he developed a strong foundation in advanced pharmaceutical formulations and nanotechnology-based therapeutics. After completing his doctoral studies, he began his professional journey at FosunPharma in Shanghai, where he contributed to pharmaceutical innovation and product development. He later joined the Jiangxi University of Traditional Chinese Medicine, where he currently serves as the Director of the Division of Innovative Pharmaceutical Sciences, leading cutting-edge research in formulation science and nanomedicine.Dr. Tu’s research focuses on developing advanced drug delivery systems, including nanocrystals, polymeric micelles, and vesicular systems, to enhance the oral bioavailability and therapeutic efficacy of poorly soluble drugs. His work also extends to exploring biopharmaceutics mechanisms to improve the in vivo performance of active pharmaceutical ingredients. His innovative approaches have positioned him at the forefront of translational pharmaceutics, bridging the gap between laboratory research and clinical applications.He is an active member of the Chinese Pharmaceutical Association and contributes his expertise as a member of the Elsevier Advisory Panel. Additionally, he serves on the Editorial Board of Chinese Chemical Letters (ISSN: 1001-8417), reflecting his strong academic presence and influence in the pharmaceutical sciences community. Dr. Tu has been awarded multiple research grants, including projects funded by the National Natural Science Foundation of China and other governmental bodies, underscoring the national and international recognition of his research excellence.Dr. Tu has published around 30 peer-reviewed papers in top-tier journals such as Chinese Chemical Letters, Drug Delivery, and the International Journal of Pharmaceutics. His representative publications include “Vesicular Drug Delivery Systems for Oral Absorption Enhancement,” “Multi-functional Chitosan Copolymer Modified Nanocrystals as Oral Andrographolide Delivery Systems for Enhanced Bioavailability and Anti-inflammatory Efficacy,” “Fabrication of Ultra-Small Nanocrystals by Formation of Hydrogen Bonds: In Vitro and In Vivo Evaluation,” “Multi-functional Chitosan Polymeric Micelles as Oral Paclitaxel Delivery Systems for Enhanced Bioavailability and Anti-Tumor Efficacy,” and “Study on the Preparation of Stabilizer-Free Silymarin Nanocrystals and Its Oral Absorption Mechanisms.”

Profile: Orcid

Featured Publications

Wang, J., Sun, Y., Meng, L., Feng, J., Cheng, M., & Tu, L. Intestinal transporters and oral absorption enhancing strategies based on these transporters. Chinese Chemical Letters.

Li, Z., Yao, L., Liu, Z., Wang, L., Ruan, H., Shen, Y., Zhang, P., Li, K., Wang, H., Fan, L., et al. Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions. Pharmaceuticals.

Tu, L., Wang, J., Sun, Y., & Wan, Y. Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport. AAPS PharmSciTech.

Zou, L., Cheng, M., Hu, K., Feng, J., & Tu, L. Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters.

He, Y., Cheng, M., Yang, R., Li, H., Lu, Z., Jin, Y., Feng, J., & Tu, L. Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane. Pharmaceutics.

Liu, W., Cheng, M., Yuan, F., He, J., Feng, Y., Jin, Y., Yang, S., Feng, J., & Tu, L. Enhancing oral bioavailability of andrographolide via sodium dodecyl sulfate and D-α-Tocopherol polyethylene glycol 1000 succinate copolymer modified nanocrystals. Journal of Drug Delivery Science and Technology.

Liu, W., Cheng, M., Lu, Z., Li, H., Feng, Y., Jin, Y., Yang, S., Feng, J., & Tu, L. Multi-functional chitosan copolymer modified nanocrystals as oral andrographolide delivery systems for enhanced bioavailability and anti-inflammatory efficacy. Drug Delivery.

Zefeng Lai | Drug Delivery Systems | Excellence in Pharmaceutical Innovation Award

Published on by Top Pharmaceutical

Prof. Dr. Zefeng Lai | Drug Delivery Systems | Excellence in Pharmaceutical Innovation Award

Guangxi Medical University | China

Prof. Dr. Zefeng Lai is a leading figure in the field of pharmaceutical science, recognized for his pioneering work in nanomedicine, drug delivery, and nanotoxicology. He serves as a Professor of Pharmaceutical Science at the School of Pharmacy, Guangxi Medical University, Nanning, China, where he has made outstanding contributions to biomedical research and academic development. Having earned his BSc and PhD from the State Key Laboratory of Crystal Materials, Shandong University, and completed postdoctoral research in Drug Delivery and Biomedical Effects of Nanomaterials, Dr. Lai’s expertise integrates material chemistry with pharmacological innovation to enhance therapeutic outcomes.His research explores the mechanisms and biomedical applications of carbon-based nanodrug carriers, focusing on their transcytosis, biodistribution, and immunological effects. He has led multiple high-impact national and provincial projects, including investigations into mesona chinensis polysaccharides, fibrinolytic enzymes from marine sources, and liver-targeted nanocarriers. His work on the biotoxicity of carboxylated single-walled carbon nanotubes using zebrafish and mammalian models has been particularly influential, advancing the global understanding of nanomaterial safety in pharmaceutical formulations.Prof. Lai’s scholarly influence is reflected in his strong research metrics, with 293 citations across 279 documents, based on 19 published papers, and an impressive h-index of 10, demonstrating his consistent impact and the recognition of his contributions by the global scientific community.His groundbreaking publications demonstrate his multidisciplinary research vision. His paper Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells presents a novel nanoplatform integrating photothermal therapy and immunomodulation for non-small cell lung cancer treatment. His work Immunogenic Nano-Phthalocyanine Enables Oxygen-Economic Photodynamic Therapy for Hepatocellular Carcinoma introduces a new generation of oxygen-efficient nanotherapeutics for liver cancer. Other notable studies include Effect of Carboxylated Single-Walled Carbon Nanotubes on the Development and Morphology of Zebrafish Embryos, High Throughput CircRNA Sequencing Analysis Reveals Novel Insights into the Mechanism of Nitidine Chloride against Hepatocellular Carcinoma, and Toxic Effect of Long-Term Intravenous Injection of Carboxylated Single-Walled Carbon Nanotubes on Kidney in Rats. His research on Nitidine Chloride Induced Colorectal Cancer HT29 Cells Apoptosis Through the Cytochrome c-Mediated Mitochondrial Pathways and Long-Term Intravenous Administration of Carboxylated Single-Walled Carbon Nanotubes Induces Persistent Accumulation in the Lungs and Pulmonary Fibrosis via the NF-κB Pathway underscores his deep engagement with molecular pharmacology and nanotoxicology.

Profile: Scopus

Featured Publications

Lai, Z., Liu, Y., He, L., Wang, X., Zhang, H., & Zhao, J. (2023). Immunogenic nano-phthalocyanine enables oxygen-economic photodynamic therapy for hepatocellular carcinoma. Biomaterials, 295, 121992.

Narendra Bagri | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Narendra Bagri | Clinical Trials | Best Researcher Award

All India Institute of Medical Sciences | India

Assoc. Prof. Dr. Narendra Bagri is a distinguished clinician and academician in the field of pediatric rheumatology, presently serving as Additional Professor in the Department of Pediatrics, Division of Pediatric Rheumatology at the All India Institute of Medical Sciences (AIIMS), New Delhi, India. A graduate and postgraduate of the Institute of Medical Sciences, Banaras Hindu University, he has built a remarkable career through a blend of clinical excellence, teaching, and groundbreaking research in pediatric autoimmune and inflammatory disorders. He completed the prestigious PRES EMERGE Fellowship in Pediatric Rheumatology at the Bristol Royal Hospital for Children, UK, under the mentorship of Prof. A.V. Ramanan, enhancing his expertise in advanced pediatric rheumatologic care and translational research.Dr. Bagri’s scientific contributions encompass numerous impactful publications addressing critical aspects of pediatric inflammatory diseases, musculoskeletal imaging, and immunological mechanisms underlying juvenile idiopathic arthritis. His research includes the longitudinal analysis of multisystem inflammatory syndrome in children temporally related to COVID-19, the evaluation of pulse dexamethasone therapy in non-systemic juvenile idiopathic arthritis, and the technical and interpretive insights into pediatric musculoskeletal ultrasound. He has also authored work on the utility of musculoskeletal ultrasound in juvenile idiopathic arthritis, the forgotten figure in the history of methotrexate, sympathetic blocks for Raynaud’s phenomena in pediatric rheumatological disorders, and the conception of a national biologics registry for pediatric rheumatology.As a principal investigator and collaborator in multiple funded research projects by the Indian Council of Medical Research (ICMR) and the Science and Engineering Research Board (SERB), Dr. Bagri has contributed extensively to the understanding of synovial fluid proteomics, biomarker discovery, and immune-pathogenic mechanisms in childhood arthritis. His pioneering efforts include the development of transitional care services, collaborative rheumatology clinics, and the initiation of diagnostic and therapeutic procedures such as ultrasound-guided intra-articular injections and synovial biopsies.Dr. Bagri is a life member of several professional bodies, including the Indian Rheumatology Association, the Pediatric Rheumatology European Society, and the Indian Academy of Pediatrics. Recognized for his outstanding contributions, he has received multiple academic honors, travel grants, and leadership roles in national guideline formulation, including contributions to WHO and IAP documents on pediatric inflammatory syndromes. His dedication to research, patient care, and education continues to shape the evolution of pediatric rheumatology in India and beyond.

Profile: Google Scholar

Featured Publications

Bagri, N. K., Jose, B., Shah, S. K., Bhutia, T. D., Kabra, S. K., & Lodha, R. (n.d.). Impact of malnutrition on the outcome of critically ill children. The Indian Journal of Pediatrics, 82(7), 601–605.

Sivasubbu, S., & Scaria, V. (n.d.). Genomics of rare genetic diseases—experiences from India. Human Genomics.

Basu, S., Kumar, A., Kapoor, K., Bagri, N. K., & Chandra, A. (n.d.). Neonatal endogenous endophthalmitis: A report of six cases. Pediatrics.

Bagri, N., Saha, A., Chandelia, S., Dubey, N. K., Bhatt, A., Rai, A., & Bhattacharya, S. (n.d.). Fireworks injuries in children: A prospective study during the festival of lights. Emergency Medicine Australasia.

Bagri, N. K., Yadav, D. K., Agarwal, S., Aier, T., & Gupta, V. (n.d.). Pericardial effusion in children: Experience from tertiary care center in northern India. Indian Pediatrics.

Kumar, A., Bagri, N. K., Basu, S., & Asthana, R. K. (n.d.). Zinc supplementation for neonatal hyperbilirubinemia: A randomized controlled trial. Indian Pediatrics.

Bagri, N. K., Deepak, R. K., Meena, S., Gupta, S. K., Prakash, S., Setlur, K., Satapathy, J., Chopra, K., Upadhyay, A. D., Ramakrishnan, S., Lodha, R., Dar, L., Trikha, A., & Kabra, S. K. (n.d.). Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: A longitudinal study. Rheumatology International.

Gupta, D., Thakral, D., Kumar, P., Kabra, S. K., Lodha, R., Kumari, R., Mohanty, S. K., … & Bagri, N. K. (n.d.). Primary immunodeficiency disorders among north Indian children. The Indian Journal of Pediatrics.

Radhakrishnanand Pullapanthula | Pharmaceutical Analysis |

Published on by Top Pharmaceutical

Prof. Dr. Radhakrishnanand Pullapanthula | Pharmaceutical Analysis | Best Researcher Award

National Institute of Pharmaceutical Education and Research | India

Prof. Dr. Radhakrishnanand Pullapanthula is a highly accomplished pharmaceutical scientist and analytical research leader with over two decades of distinguished experience in both industry and academia. A quality-minded professional, he has built a reputation for excellence in analytical compliance, regulatory affairs, and strategic development in the pharmaceutical sector. With a career spanning more than 24 years, including over 12 years in senior management positions, Dr. Pullapanthula has contributed significantly to analytical research and development, project leadership, and regulatory compliance within the framework of international standards such as cGMP, FDA, and ICH. His expertise lies in analytical method development, impurity profiling, physico-chemical characterization, and life cycle management of complex pharmaceutical products, including ANDA and NDA applications.Dr. Radhakrishnanand has been a driving force in setting up GMP-compliant analytical laboratories and implementing best practices for quality and regulatory adherence. His technical mastery covers LC-MS/MS, GC-MS/MS, ICP-MS, LC-Q-TOF-MS/MS, HPLC, GC, and IC techniques, enabling him to develop and validate advanced analytical methods for drug substances, formulations, excipients, food, and herbal products. His pioneering work in impurity profiling, degradation chemistry, and reference standard qualification has had a lasting impact on analytical R&D and pharmaceutical quality systems. As a leader, he has successfully coordinated the establishment of ISO 17025:2005 and ISO 17025:2017 certified laboratories, and played a key role in achieving NABL accreditation and ISO certification for analytical facilities at Daicel Chiral Technologies–India and United States Pharmacopeia.In addition to his industrial achievements, Dr. Radhakrishnanand has held prominent academic and administrative roles, serving as Registrar (In-Charge) and a board-level member in key scientific and innovation committees. His contributions extend to serving as an Expert Member on several national panels including the DST-Technology Development Board, ANRF-Life Sciences, NGCMA, and the Pharmaceutical Policy Committee of Tripura. As a Board of Director at the Atal Innovation Mission, NIPER-Guwahati, he has actively promoted innovation and research excellence in the pharmaceutical sciences. He currently manages and coordinates major projects such as the “Quality Assessment and Value Addition Centre for Herbal Industry in the North-Eastern States of India,” funded by the Ministry of Commerce under the TIES scheme, with a project worth exceeding twenty crores.

Profile: Google Scholar

Featured Publications

Rao, D. V. S., Radhakrishnanand, P., Suryanarayana, M. V., & Himabindu, V. (n.d.). A stability-indicating LC method for candesartan cilexetil. Chromatographia.

Kumari Rayala, V. V. S. P., Kandula, J. S., & Radhakrishnanand, P. (n.d.). Advances and challenges in the pharmacokinetics and bioanalysis of chiral drugs. Chirality.

Rao, D. V. S., & Radhakrishnanand, P. (n.d.). Stress degradation studies on dutasteride and development of a stability-indicating HPLC assay method for bulk drug and pharmaceutical dosage form. Chromatographia.

Kaja, R. K., Surendranath, K. V., Radhakrishnanand, P., Satish, J., & others. (n.d.). A stability-indicating LC method for deferasirox in bulk drugs and pharmaceutical dosage forms. Chromatographia.

Vishnuvardhan, C., Radhakrishnanand, P., Navalgund, S. G., Atcha, K. R., & others. (n.d.). RP-HPLC method for the simultaneous estimation of eight cardiovascular drugs. Chromatographia.

Rao, D. V. S., Radhakrishnanand, P., & Himabindu, V. (n.d.). Stress degradation studies on tadalafil and development of a validated stability-indicating LC assay for bulk drug and pharmaceutical dosage form. Chromatographia.

Subba Rao, D. V., Surendranath, K. V., Radhakrishnanand, P., & others. (n.d.). A stability-indicating LC method for vardenafil HCl. Chromatographia.

Muhammad Musa Khan | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Muhammad Musa Khan | Drug Safety and Risk Management | Best Researcher Award

Hainan Intitute of Zhejiang University | China

Assoc. Prof. Dr. Muhammad Musa Khan is an accomplished entomologist and agricultural researcher whose scientific endeavors bridge environmental toxicology, pest management, and agroecological sustainability. His academic journey reflects a strong foundation in agricultural entomology, leading to advanced expertise in pest control and ecotoxicology. Currently serving as an Associate Researcher at the Hainan Institute of Zhejiang University in China, Dr. Khan plays a leading role in investigating pesticide toxicity, insecticide resistance, and the ecological risks associated with chemical pest management in rice agroecosystems. His leadership and research contributions under the guidance of distinguished scientists have advanced global understanding of integrated pest management strategies and sustainable agricultural practices.Dr. Khan’s research experience extends to his postdoctoral work at South China Agricultural University, where he explored the management of whiteflies and diamondback moths through ultraviolet light exposure, revealing insights into immunity suppression and its implications for biological control agents. His earlier doctoral research at Huazhong Agricultural University focused on assessing the ecological risks of modern insecticides such as emamectin benzoate and chlorantraniliprole on beneficial predators like Paederus fuscipes, a natural enemy of the brown planthopper. He also evaluated the “push and pull” pest management approach using essential oils and synthetic chemicals, blending ecological knowledge with innovative pest control methods. His master’s and undergraduate studies laid the foundation for his deep understanding of insect–plant interactions, particularly in cotton crops where he analyzed morphological and biochemical traits contributing to pest resistance.A versatile and skilled experimental researcher, Dr. Khan possesses extensive expertise in molecular and biochemical methodologies. His technical proficiency includes DNA and RNA extraction, PCR, RT-qPCR, gene cloning, enzyme activity analysis, and protein profiling through SDS-PAGE and Western blotting. Additionally, his software expertise spans advanced data analysis and visualization platforms such as R-Studio, SPSS, SigmaPlot, and MEGA-X, along with strong skills in scientific illustration using BioRender and AI-based tools for bioinformatics. This blend of laboratory precision and digital innovation positions him as a modern scientist capable of integrating complex datasets into actionable scientific insights.

Profile: Google Scholar

Featured Publications

Siddiqui, J. A., Khan, M. M., Bamisile, B. S., Hafeez, M., Qasim, M., & Rasheed, M. T., et al. (2022). Role of insect gut microbiota in pesticide degradation: A review. Frontiers in Microbiology.

Hafeez, M., Ullah, F., Khan, M. M., Li, X., Zhang, Z., Shah, S., Imran, M., Assiri, M. A., et al. (2022). Metabolic-based insecticide resistance mechanism and ecofriendly approaches for controlling of beet armyworm Spodoptera exigua: A review. Environmental Science and Pollution Research.

Siddiqui, J. A., Bamisile, B. S., Khan, M. M., Islam, W., Hafeez, M., Bodlah, I., & Xu, Y. (2021). Impact of invasive ant species on native fauna across similar habitats under global environmental changes. Environmental Science and Pollution Research.

Khan, M. M., Nawaz, M., Hua, H., Cai, W., & Zhao, J. (2018). Lethal and sublethal effects of emamectin benzoate on the rove beetle Paederus fuscipes, a non-target predator of rice brown planthopper Nilaparvata lugens. Ecotoxicology and Environmental Safety.

Liu, S., Zhao, J., Hamada, C., Cai, W., Khan, M., Zou, Y., & Hua, H. (2019). Identification of attractants from plant essential oils for Cyrtorhinus lividipennis, an important predator of rice planthoppers. Journal of Pest Science.

Elli Anna Kotsailidi | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Elli Anna Kotsailidi | Clinical Trials | Best Researcher Award

University of Rochester | United States

Assist. Prof. Dr. Elli Anna Kotsailidi is a distinguished academic and clinician specializing in periodontology, implant dentistry, and health professions education. She serves as an Assistant Professor of Clinical Dentistry at the University of Rochester, School of Medicine and Dentistry, and is a key faculty member at the Eastman Institute for Oral Health. With a strong foundation in dental surgery and advanced expertise in periodontal and implant sciences, she has built a remarkable career combining clinical excellence, academic leadership, and educational innovation.Dr. Kotsailidi’s academic journey began with her dental degree from the National and Kapodistrian University of Athens, where she demonstrated early dedication to clinical precision and scientific inquiry. Her pursuit of advanced specialization led her to the Eastman Institute for Oral Health at the University of Rochester, where she completed rigorous training in periodontology and implant dentistry, refining her skills in evidence-based patient care and complex surgical procedures. Further expanding her professional vision, she completed a master’s degree in Health Professions Education at the Warner School of Education, University of Rochester, focusing on curriculum development, equitable teaching, and the enhancement of academic excellence in dental education.Her professional career reflects an unwavering commitment to both patient-centered care and academic mentorship. As Program Director and former Clinic Director in the Department of Periodontology at the Eastman Institute for Oral Health, she has played a pivotal role in shaping clinical programs, overseeing resident training, and ensuring adherence to the highest standards of quality assurance and ethical practice. Her role integrates patient management, surgical supervision, curriculum coordination, and leadership in interdisciplinary dental education involving periodontics, prosthodontics, and general dentistry.Dr. Kotsailidi’s teaching philosophy is deeply rooted in inclusivity, collaboration, and innovation. She has co-directed and taught numerous courses, including Cell Biology of Disease, Introduction to Periodontology, Oral Implantology, ABP Mock Boards, and the Literature Review Series in Periodontics and Dental Implantology. Her approach emphasizes integrative learning, clinical reasoning, and the practical application of scientific knowledge in patient care. She is also an active mentor, serving on research committees for master’s students, guiding systematic reviews and meta-analyses that contribute to evidence-based dentistry and global oral health advancement.

Profile: Orcid

Featured Publications

Umbrio, L. R. N., Pham, H. M., Barmak, A. B., Assery, N., & Kotsailidi, E. A. (2025). Association between selective serotonin reuptake inhibitors and the periodontal status: A systematic review and meta-analysis of observational clinical studies. Evidence-Based Dentistry.

Benzaquen, S. I., Torabi Ardakani, M., Tsigarida, A., Ercoli, C., Barmak, B., Chochlidakis, K. M., & Kotsailidi, E. A. (2025). Biologic complications with removable partial dentures assisted by short implants: A 34-month pilot randomized controlled clinical trial. The Journal of Prosthetic Dentistry.

Kotsailidi, E. A., Johnson, L., Burns, C., Rossouw, P. E., & Michelogiannakis, D. (2025). Surgically facilitated orthodontics with clear aligners for severe malocclusion and gingival recessions. Clinical Advances in Periodontics.

Burns, C., Kotsailidi, E. A., Alshuraim, F., Dadjoo, S., Tzouma, K., Pedrinaci, I., Rossouw, P. E., & Michelogiannakis, D. (2024). Interdisciplinary orthodontic treatment with digitally-guided autotransplantation in a patient with a missing permanent maxillary left lateral incisor and a supernumerary mandibular incisor. AJO-DO Clinical Companion.

Basant Farag | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Basant Farag | Drug Discovery and Development | Best Researcher Award

Zagazig University Faculty of Science | Egypt

Dr. Basant Farag is a distinguished organic chemist and assistant lecturer at the Department of Chemistry, Faculty of Science, Zagazig University, Egypt, with extensive expertise in the synthesis, biological evaluation, and computational studies of heterocyclic compounds. She completed her Ph.D. in Organic Chemistry at Zagazig University, building on her M.Sc. and B.Sc. degrees in the same field, demonstrating a consistent commitment to advancing chemical sciences. Her academic career encompasses teaching, mentoring students, and conducting cutting-edge research while serving as a teaching assistant and assistant lecturer, preparing lectures, evaluating students, and engaging in independent research projects. Dr. Farag is also an accomplished international reviewer for numerous journals including Chemistry Select, Eurasian Journal of Chemistry, Journal of Molecular Structure, Bioorganic Chemistry, and International Journal of Biological Macromolecules, highlighting her broad expertise and recognition in the global scientific community.Her research portfolio includes pioneering studies in the design and synthesis of biologically active heterocyclic compounds, focusing on pharmacologically relevant molecules with anticancer, antimicrobial, and antitubercular properties. Her notable publications include Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase, Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents, Green Synthesis and Molecular Docking Study of Some New Thiazoles Using Terephthalohydrazide Chitosan Hydrogel as Ecofriendly Biopolymeric Catalyst, Green Route Synthesis and Molecular Docking of Azines Using Cellulose Sulfuric Acid under Microwave Irradiation, Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-Dihydropyrido[2,3-d:6,5-d′]Dipyrimidine-2,4,6,8-Tetraone Derivatives and Pyrido[2,3-d], Synthesis, Molecular Docking Study, and Biological Evaluation of New Thiadiazole and Thiazole Derivatives Incorporating Isoindoline-1,3-Dione Moiety as Anticancer and Antimicrobial Agents, Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis, Cyanauric Chloride as a Key Precursor and a Core Component for Three-Armed Triazolopyrimidines: Recent Finding About SARs and Docking Analyses, Chitosan–Sulfonic Acid-Catalyzed Green Synthesis of Naphthalene-Based Azines as Potential Anticancer Agents, Synthesis, Molecular Docking, In Silico Study, and Evaluation of Bis-Thiazole-Based Curcumin Derivatives as Potential Antimicrobial Agents, and Design and Synthesis of Novel Hybrids Incorporating Thiadiazole or Thiazole-Naphthalene: Anticancer Assessment and Molecular Docking Study.

Profile: Google Scholar

Featured Publications

Abolibda, T. Z., Fathalla, M., Farag, B., Zaki, M. E. A., & Gomha, S. M. (n.d.). Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase. Molecules.

Ibrahim, M. S., Farag, B., Al-Humaidi, J. Y., Zaki, M. E. A., Fathalla, M., & Gomha, S. M. (n.d.). Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents. Molecules.

Gomha, S. M., Riyadh, S. M., Alharbi, R. A. K., Zaki, M. E. A., Abolibda, T. Z., & Farag, B. (n.d.). Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation. Crystals.

Al-Humaidi, J. Y., Gomha, S. M., El-Ghany, N. A. A., Farag, B., Zaki, M. E. A., et al. (n.d.). Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst. Catalysts.

Hussein, A. M., Gomha, S. M., El-Ghany, N. A. A., Zaki, M. E. A., Farag, B., et al. (n.d.). Green biocatalyst for ultrasound-assisted thiazole derivatives: Synthesis, antibacterial evaluation, and docking analysis. ACS Omega.

Mokbel, W. A., Hosny, M. A., Gomha, S. M., Zaki, M. E. A., Farag, B., El Farargy, A. F., et al. (n.d.). Synthesis, molecular docking study, and biological evaluation of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents. Results in Chemistry.

Hui Li | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hui Li | Drug Delivery Systems | Best Researcher Award

Woosuk University | South Korea

Dr. Hui Li is a distinguished medical scientist and otolaryngologist whose work bridges clinical medicine, translational research, and pharmaceutical innovation. He earned his Ph.D. in Translational Medicine from Seoul National University College of Medicine in Korea, where his research focused on the molecular mechanisms underlying hearing loss and radiation-induced cellular changes. Prior to his doctoral training, he completed both his Master’s and Bachelor’s degrees in Clinical Medicine from Yanbian University of Medicine in China, establishing a strong foundation in clinical diagnostics, therapeutic approaches, and patient-centered medical care.Dr. Li’s professional journey reflects an impressive progression from clinical expertise to cutting-edge biomedical research. He began his career as a medical doctor and otolaryngologist at Yanbian Yongjeong National Hospital, where he honed his clinical acumen in diagnosing and treating ear, nose, and throat disorders. His clinical excellence led him to serve as a resident and research fellow in the Department of Otolaryngology at the Affiliated Hospital of Yanbian University of Medicine, where he began integrating research into his clinical practice. He later worked as a specialist at the Yanbian National Ophthalmology & Otolaryngology Hospital, focusing on complex cases of auditory and vestibular dysfunction. These formative years in medical practice equipped him with invaluable clinical insight that continues to inform his research in translational medicine and pharmacotherapeutics.Dr. Li transitioned into academic research with his appointment as a doctoral researcher at the Department of Translational Medicine (Otolaryngology) at Seoul National University College of Medicine. There, he conducted pivotal studies on novel therapeutic delivery systems, inner ear protection mechanisms, and the molecular pathways involved in hearing impairment. His research excellence earned him postdoctoral appointments at the Cancer Research Institute within the same university, where he explored immune-modulatory effects of radiotherapy and the potential of macrophage polarization in mitigating cancer progression. Currently, he serves as a Postdoctoral Research Fellow at the Laboratory of Biopharmaceutics, Industry-Academia Cooperation Foundation, Woosuk University, Korea, where he investigates advanced drug formulations, biopharmaceutical delivery mechanisms, and the translational potential of controlled-release therapeutics.

Profile: Scopus

Featured Publications

Li, J., Wang, H., Zhang, Y., & Chen, L. (2022). Comprehensive intervention and effect of martial arts routines on children with autism. Journal of Environmental and Public Health, 2022.

Turnwait Michael | Regulatory Affairs | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Turnwait Michael | Regulatory Affairs | Best Researcher Award

University of Johannesburg | South Africa

Dr. Turnwait Michael is a distinguished social scientist and public health researcher whose work bridges sociology, demography, and epidemiology to address some of the most pressing health challenges across Africa. He holds a Ph.D. in Sociology with a specialization in Medical Demography from the University of Ibadan, Nigeria, an MPH in Epidemiology and Medical Statistics from the College of Medicine, University of Ibadan, an MSc in Sociology/Demography, and a BSc in Sociology from Niger Delta University. His robust academic foundation is further strengthened by specialized certifications and global training in family planning, public health nutrition, implementation research, antimicrobial resistance, and project management from international institutions in the USA, Canada, Malaysia, and Nigeria.Dr. Michael currently serves as a Postdoctoral Research Fellow at the University of Johannesburg, South Africa, where he conducts advanced research on social determinants of health, reproductive and adolescent health, gender norms, and health systems strengthening. His postdoctoral work extends to collaborative projects supported by competitive international grants such as the EU Intra-Africa Mobility Grant and the University Capacity Development Programme (UCDP) Grant. In this role, he also mentors postgraduate students, contributes to academic publications, and engages in interdisciplinary fundraising efforts for health research and policy innovation.Before joining the University of Johannesburg, Dr. Michael served as Lecturer II in Medical Sociology and Demography at Hallmark University, Nigeria, where he taught and supervised undergraduate and postgraduate research on applied demography, health sociology, social statistics, and research methods. He has also contributed to national policy through his role as a Technical Analyst with the Presidential Health Sector Committee in Nigeria, where he worked on health policy memoranda, pharmaceutical regulations, and universal health coverage frameworks. His consultancy experience with the development Research and Projects Centre (dRPC) spans reproductive rights, gender-based violence, climate change, child marriage, migration, and digital education initiatives.

Profile: Google Scholar

Featured Publications

Michael, T. O., & Odeyemi, M. A. (2017). Nigeria’s population policies: Issues, challenges and prospects. Ibadan Journal of the Social Sciences.

Michael, T. O., Ojo, T. F., Ijabadeniyi, O. A., Ibikunle, M. A., Oni, J. O., & Agboola, A. A. (2024). Prevalence and factors associated with contraceptive use among sexually active adolescent girls in 25 sub-Saharan African countries. PLOS ONE..

Michael, T. O., Agbana, R. D., Ojo, T. F., Kukoyi, O. B., Ekpenyong, A. S., & Ukwandu, D. (2021). COVID-19 pandemic and unmet need for family planning in Nigeria. Pan African Medical Journal.

Agbana, R. D., Michael, T. O., & Ojo, T. F. (2023). Family planning method discontinuation among Nigerian women: Evidence from the Nigeria Demographic and Health Survey 2018. Journal of Taibah University Medical Sciences.

Michael, T. O., Nwokocha, E. E., & Agbana, R. D. (2023). Issues in antenwatal care services utilization among unmarried adolescents in Akwa Ibom State, Nigeria. Journal of Population and Social Studies.

Michael, T. O., & Scent, G. A. T. (2017). Correlates of contraceptive use and the desire for fewer children in Nigeria. The Nigerian Journal of Sociology and Anthropology.

Ekpenyong, A. S., & Turnwait, M. O. (2016). Social media and sexual reproductive health behaviour among adolescents in Bayelsa State, Nigeria. American International Journal of Research in Humanities, Arts and Social Sciences.